Base editing technology invented at Rutgers, The State University of New Jersey, and exclusively licensed to Revvity, Inc. subsidiary Horizon Discovery, has been sub-licensed to biopharmaceutical company AstraZeneca to support its creation of cell therapies for the treatment of cancer and immune-mediated diseases.
The Office for Research is excited to announce that Jeetendra Eswaraka, DVM, PhD, DACLAM, Associate Vice President for Rutgers University Animal Care has been elected to serve on the Council of the European College of Laboratory Animal Medicine (ECLAM), one of the 27 specialist colleges recognized by the European Board of Veterinary Specializations.